Department of Paediatrics, KK Woman's and Children's Hospital, Singapore.
J Allergy Clin Immunol. 2012 Dec;130(6):1361-7. doi: 10.1016/j.jaci.2012.08.048. Epub 2012 Oct 23.
On the basis of the proven prebiotic effects of oligosaccharides in cow's milk formula (CMF) in infants, CMFs are supplemented with oligosaccharides.
We present a series of 5 cases of cow's milk-tolerant but atopic patients with a history of respiratory allergies. All had anaphylaxis after the ingestion of CMF supplemented with short-chain galacto-oligosaccharide (scGOS). The allergen trigger was investigated.
Clinical histories were collated. Skin prick tests (SPTs) and basophil activation tests (BATs) were carried out with the eliciting CMF that triggered anaphylaxis, with or without supplemented prebiotics (scGOS) and with scGOS fractions containing oligosaccharides of different chain lengths.
The median age of presentation was 6 years (range, 5-38 years). Anaphylaxis occurred within 30 minutes of the first known exposure to CMF supplemented with prebiotics in all patients. Only 1 patient was subjected to oral challenge, which resulted in an anaphylactic reaction. All patients demonstrated IgE sensitization through SPTs and BATs to scGOS and fractions of scGOS containing 3 sugar units or greater but not to cow's milk or long-chain fructo-oligosaccharide. Eight child control subjects tolerant to regular ingestion of scGOS-supplemented CMF and 1 adult volunteer were found to have negative results to scGOS through SPTs and BATs. In addition, in vitro BATs with donor basophils sensitized with sera from 2 of the 3 reported cases showed reactions to scGOS. The scGOS-induced basophil activation was inhibited in the presence of wortmannin, a phosphatidylinositol 3-kinase inhibitor.
This study describes an unusual form of IgE-mediated anaphylaxis triggered by low-molecular-weight oligosaccharides in scGOS. The primary sensitizer for this phenomenon requires further investigation.
基于牛乳配方(CMF)中寡糖对婴儿的已证实的益生元作用,CMF 中添加了寡糖。
我们报告了一系列 5 例牛乳耐受但特应性患者的病例,这些患者有呼吸道过敏史。所有患者在摄入添加短链半乳糖寡糖(scGOS)的 CMF 后均发生过敏反应。我们对过敏原触发因素进行了研究。
整理临床病史。对引发过敏反应的引发 CMF 进行皮肤点刺试验(SPT)和嗜碱性粒细胞激活试验(BAT),并分别在添加或不添加 scGOS 以及添加含有不同链长寡糖的 scGOS 片段的情况下进行检测。
首发年龄中位数为 6 岁(范围,5-38 岁)。所有患者在首次摄入添加 scGOS 的 CMF 后 30 分钟内发生过敏反应。仅 1 例患者接受了口服挑战,导致过敏反应。所有患者通过 SPT 和 BAT 对 scGOS 和含有 3 个糖单位或更多糖单位的 scGOS 片段均显示 IgE 致敏,但对牛乳或长链果聚糖不致敏。8 例儿童对照受试者耐受常规摄入添加 scGOS 的 CMF,1 例成年志愿者通过 SPT 和 BAT 对 scGOS 呈阴性反应。此外,用来自报告的 3 例中的 2 例的血清对供体嗜碱性粒细胞进行致敏的体外 BAT 显示对 scGOS 的反应。scGOS 诱导的嗜碱性粒细胞激活在存在磷脂酰肌醇 3-激酶抑制剂wortmannin 时受到抑制。
本研究描述了一种由 scGOS 中的低分子量寡糖引发的不常见的 IgE 介导的过敏反应形式。这种现象的主要致敏原需要进一步研究。